Day: February 4, 2026

NORBIT – Invitation to presentation of NORBIT’s fourth quarter results, 11 February 2026

Written by Customer Service on February 4, 2026. Posted in Mergers And Acquisitions.

Trondheim, Norway, 4 February 2026: NORBIT, a global provider of tailored technology to carefully selected applications, will announce its results for the fourth quarter of 2025 on Wednesday 11 February 2026. The interim report for the fourth quarter and the presentation material will be available from 07:00 am CET at the company’s homepage, www.norbit.com and Euronext Oslo Børs’ news site, www.newsweb.no (http://www.newsweb.no). CEO Per Jørgen Weisethaunet and CFO Per Kristian Reppe will present the results at 09:00 am CET. Please use the following link to register for the webcast: https://teams.microsoft.com/l/meetup-join/19%3ameeting_M2RmNmZlYjMtMmNiOS00ODQ5LTk0NjYtMDYwZDZmYzI5YzY4%40thread.v2/0?context=%7b%22Tid%22%3a%22d02701f9-3b23-4b3f-8fce-29ed54632bf8%22%2c%22Oid%22%3a%2249eee719-db83-4ef4-aca0-334090732543%22%7d For further...

Borregaard ASA: EBITDA1 of NOK 405 million in the 4th quarter 2025

Written by Customer Service on February 4, 2026. Posted in Earnings Releases And Operating Results.

Borregaard’s operating revenues increased to NOK 1,833 million (NOK 1,744 million)2 in the 4th quarter of 2025. EBITDA1 was NOK 405 million (NOK 398 million). The result in BioMaterials increased, while BioSolutions and Fine Chemicals had lower results compared with the 4th quarter of 2024. In BioSolutions, high deliveries of biovanillin and sustained growth in sales to agriculture were more than offset by increased costs. For BioMaterials, higher sales prices and lower wood and energy costs, more than compensated for other cost increases. For Fine Chemicals, lower bioethanol sales prices were partly offset by a strong result for fine chemical intermediates. Net currency effects were slightly positive for the Group. In the 4th quarter of 2025, Borregaard has made a total impairment of NOK 245 million of its investments in the bio-based...

Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025

Written by Customer Service on February 4, 2026. Posted in Earnings Releases And Operating Results.

Ad hoc announcement pursuant to Art. 53 LR Full yearNet sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD)Sales growth driven by continued strong performance from priority brands including Kisqali (+57% cc), Kesimpta (+36% cc), Pluvicto (+42% cc), Scemblix (+85% cc) and Cosentyx (+8% cc) Core operating income margin1 was 40.1%, +210 basis points (cc)Operating income grew +25% (cc, +21% USD); net income up +19% (cc, +17% USD) Core EPS1 grew +17% (cc, +15% USD) to USD 8.98 Free cash flow1 of USD 17.6 billion (+8% USD) driven by higher net cash flows from operating activitiesFourth quarterNet sales -1% (cc, +1% USD), impacted by US generic erosion and revenue deduction adjustments; core operating income +1% (cc, +1% USD)Priority brands continued their strong momentum including Kisqali (+44% cc),...

CREDIT AGRICOLE SA: Fourth quarter 2025 and full-year 2025 results – DYNAMIC ACTIVITY AND STRONG RESULTS IN 2025

Written by Customer Service on February 4, 2026. Posted in Earnings Releases And Operating Results.

DYNAMIC ACTIVITY AND STRONG RESULTS IN 2025 CRÉDIT AGRICOLE S.A. CRÉDIT AGRICOLE GROUP €m 2025 Var. 2025/2024 2025 Var. 2025/2024 Revenues 28,079 +3.3% 39,558 +3.9% Expenses -15,628 +4.9% -23,568 +3.7% Gross Operating Income 12,451 +1.3% 15,990 +4.3% Cost of risk -1,973 +6.6% -3,452 +8.2% Net income Group share 7,074 -0.2% 8,754 +1.3% Cost/income ratio 55.7% +0.9 pp 59.6% -0.1 pp HIGH FULL-YEAR RESULTSHigh full-year results and profitability (>€7bn for Crédit Agricole S.A., return on tangible equity of 13.5%), driven by record annual revenues that were able to absorb the additional corporate income tax charge (Crédit Agricole Group: €280m, Crédit Agricole S.A €147m) Quarterly results impacted by the effect of the first consolidation of Banco BPM and high-level...

Ringkjøbing Landbobank’s annual report for 2025

Written by Customer Service on February 4, 2026. Posted in Public Companies.

Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeOther stakeholders 4 February 2025Ringkjøbing Landbobank’s annual report for 2025 The bank’s board of directors and general management today approved the annual report for 2025. For 2025, net profit at the top of the announced expectations for the year is realized with DKK 2,313 million. The bank is satisfied with this development.Core earnings(DKK million) 2025 2024 2023 2022 2021Total core income 4,089 4,068 3,828 2,862 2,433Total expenses and depreciation 1,080 1,044 963 891 817Core earnings before impairment charges for loans 3,009 3,024 2,865 1,971 1,616Impairment charges for loans etc. +41 +3 -1 -2 -68Core earnings 3,050 3,027 2,864 1,969 1,548Result for the portfolio etc. +26 +62 -7 -69 +7Special costs 20 20 20 20 17Profit before tax 3,056 3,069 2,837 1,880 1,538Profit...

SCOR January 2026 P&C Reinsurance Renewals: Selective growth in a competitive pricing environment

Written by Customer Service on February 4, 2026. Posted in Earnings Releases And Operating Results.

Press release4 February 2026 – N° 03 January 2026 P&C Reinsurance Renewals Selective growth in a competitive pricing environmentIn a competitive pricing environment, SCOR grows its P&C portfolio selectively, seizing profitable opportunities while maintaining a strong underwriting discipline. During the January 2026 P&C renewals, SCOR delivers EGPI1 growth of 4.7% for traditional reinsurance and 80.5% for Alternative Solutions. With its diversified portfolio mix and retrocession buying, SCOR achieves an expected increase in its underwriting ratio of 2.0 percentage points. Supported by its Tier 1 franchise and active portfolio steering, SCOR achieves targeted growth: EGPI1 increase of 7.4% for P&C Lines, with growth driven by a flight-to-quality, by markets in APAC and North America, and by core...

Equinor to commence first tranche of the 2026 share buy-back programme

Written by Customer Service on February 4, 2026. Posted in Public Companies.

Equinor (OSE: EQNR, NYSE: EQNR) will on 5 February 2026 commence the first tranche of up to USD 375 million of the share buy-back programme for 2026, as announced in relation with the company’s fourth quarter results on 4 February 2026. In this first tranche of the share buy-back programme for 2026, shares for up to USD 123.75 million will be purchased in the market, implying a total tranche of up to USD 375 million including shares to be redeemed from the Norwegian State. The tranche will end no later than 30 March 2026. Equinor announces a share buy-back programme of up to USD 1.5 billion for 2026, including shares to be redeemed from the Norwegian State. The share buy-back programme will be subject to market outlook and balance sheet strength and be structured into tranches where Equinor will buy back shares for a certain value in USD...

Equinor ASA: Key information relating to proposed cash dividend for fourth quarter 2025

Written by Customer Service on February 4, 2026. Posted in Public Companies.

Key information relating to the proposed cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for fourth quarter 2025. Cash dividend amount: 0.39 Announced currency: USD Last day including rights: 12 May 2026 Ex-date Oslo Børs: 13 May 2026 Ex-date New York Stock Exchange: 15 May 2026 Record date: 15 May 2026 Payment date: 27 May 2026 Date of approval: the proposed cash dividend is subject to approval by the annual general meeting of Equinor ASA on 12 May 2026. Other information: The cash dividend per share in NOK will be communicated 21 May 2026. This information is published in accordance with the requirements of the Continuing Obligations and is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act.

Equinor fourth quarter and full year 2025 results

Written by Customer Service on February 4, 2026. Posted in Earnings Releases And Operating Results.

Equinor (OSE:EQNR, NYSE:EQNR) delivered an adjusted operating income* of USD 6.20 billion and USD 1.55 billion after tax* in the fourth quarter of 2025. Equinor reported a net operating income of USD 5.49 billion and a net income of USD 1.31 billion. Adjusted net income* was USD 2.04 billion, leading to adjusted earnings per share* of USD 0.81. The fourth quarter and full year were characterised by:Strong production and operational performance, delivering 6% production growth in the quarter and 3.4% for the full year Continued high-grading of portfolio Cost and capital disciplineTaking action to strengthen competitiveness, cash flow and robustnessStrategic priorities guiding capital allocation– Develop the NCS to maximise value– Focused growth in international oil and gas– Building an integrated power business Strengthening...

Nova Minerals Plans to Redomicile to the United States and Seeks 100% Ownership of the Estelle Project

Written by Customer Service on February 4, 2026. Posted in Public Companies.

Melbourne, Australia, Feb. 03, 2026 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) ) a gold and critical minerals exploration stage company focused on advancing the Estelle Gold and Critical Minerals Project in Alaska, U.S.A., announces that, following the loss of its foreign private issuer (FPI) status effective 1 July 2026, it intends to undertake a corporate reorganization. This will include a planned redomiciliation to the United States while maintaining its dual ASX and Nasdaq listings, pursuing the acquisition of the remaining 15% interest in the Estelle Gold and Critical Minerals Project, and initiating a search for a U.S.-based Chief Financial Officer (CFO) with significant mining sector and U.S. GAAP accounting experience. Highlights • As a result of the majority...

Day: February 4, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals